Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Japanese patients with solid malignant tumors (Q44471337)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Japanese patients with solid malignant tumors |
scientific article |
Statements
1 reference
Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Japanese patients with solid malignant tumors (English)
1 reference
K Nakagawa
1 reference
T Tamura
1 reference
S Negoro
1 reference
S Kudoh
1 reference
N Yamamoto
1 reference
N Yamamoto
1 reference
K Takeda
1 reference
H Swaisland
1 reference
I Nakatani
1 reference
M Hirose
1 reference
R-P Dong
1 reference
M Fukuoka
1 reference
1 June 2003
1 reference
1 reference
14
1 reference
6
1 reference
922-930
1 reference
Identifiers
1 reference
1 reference